Publications
89
Citations
335
Est. group size
—
Recurring co-author estimate
Active years
7
Publishing since 2020
Benjamin N. Schmeusser conducts clinical research in urologic oncology, focusing mainly on kidney (renal cell carcinoma) and bladder cancers. A recurring emphasis is on how a patient's body composition, muscle mass (sarcopenia), and frailty relate to surgical outcomes and survival, alongside studies of kidney function measurement and cancer prognostic markers.
Publication activity grew rapidly, rising from a single paper in 2020 to a peak of 33 in 2023, then settling to a still-high output in the following years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Computerized tomography‐derived body composition metrics are associated with 24‐h urine lithogenic parameters
BJUI Compass · 2026
- Erratum: Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance
JCO Oncology Practice · 2026
- Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus
World Journal of Urology · 2026
- A narrative review of definitive ureteral reconstructive surgical techniques
AME Medical Journal · 2025
- Sarcopenia Thresholds Derived From Healthy Adult Populations Predict Survival in Patients With Cancer
JCSM Communications · 2025
- Comparing the long-term prognosis and renal function changes of partial nephrectomy (PN) and radical nephrectomy (RN) in T1 stage renal cell carcinoma patients
Translational Andrology and Urology · 2025
- Assessing the ability of Timed Up and Go and Modified Frailty Index-5 compared to Fried frailty index to objectively identify frail patients undergoing evaluation for surgery
Surgical Oncology Insight · 2025
- Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry
World Journal of Urology · 2025
- Point of Care Urinalysis in Patients With Renal Cell Carcinoma Has Prognostic Value
JU Open Plus · 2025
- POINT OF CARE URINALYSIS IN PATIENTS WITH RENAL CELL CARCINOMA HAS PROGNOSTIC VALUE
Urologic Oncology Seminars and Original Investigations · 2025
- MP23-20 THE ABILITY OF TIMED-UP & GO TO PREDICT PATIENT FRIED FRAILTY IN PATIENTS UNDERGOING SURGICAL EVALUATION IN AN OUTPATIENT UROLOGY CLINIC
The Journal of Urology · 2025
- Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment
Translational Andrology and Urology · 2025
- Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance
JCO Oncology Practice · 2025
- Differences in preoperative frailty assessment of surgical candidates by sex, age, and race
Surgery Open Science · 2024
- A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications
Urology · 2024
- The Journal of Urology×12
- Journal of Clinical Oncology×8
- Urologic Oncology Seminars and Original Investigations×6
- Translational Andrology and Urology×5
- Urology×5
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile